GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75N95019F00089PPD DEVELOPMENT LP

Overview

Award facts

Net obligations
$1.82M
$1,820,177of $2.05M potential value
Outlays (paid to date)
$43.54K
$43.54K paid of $1.82M obligated$43,544
Period of performance
Jul 1, 2019 to Mar 10, 2025
Ended
Modifications
5
Latest action Sep 17, 2025
Contract type
Delivery order
PIID 75N95019F00089

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

BUCKPITT-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19186 (EC5026) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL METHODS DEVELOPMENT FOR CLINICAL TRIAL EXECUTION

Dates and value

Award date
Signed on Jun 28, 2019
Potential end of performance
Jun 29, 2026
Current value
$1,820,177Base and exercised options
Potential value (if all options are exercised)
$2,048,932
Parent contract vehicle
HHSN271201600005I (IDC, multiple award) — 7 orders recorded under it

Obligations by fiscal year of action

  • FY2025: -$271,629 (de-obligation)
  • FY2024: -$1,156 (de-obligation)
  • FY2020: $1,705,933
  • FY2019: $387,029

Total across 4 fiscal years: $1,820,177

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 17, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationWILMINGTON, NC
UEIZANENSW6C665
CAGE code3FAW2
Business sizeOther than small businessSize at award, per the contracting officer
Parent companyPPD DEVELOPMENT LP

Business types and certifications

For-profit organization

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NINDS
Funded from
National institute of neurological disorders and stroke (0886)Program activities075-0886Federal accounts (agency financial reports)

Place of performance

Place of performance
Wilmington, New Hanover County, North Carolina 28401-3331
Congressional district (place of performance)
NC-07As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
Not reported
Contract pricing
Cost plus fixed feeU
Offers received
2

Solicitation and notices

Solicitation ID
NIHNINDS1501(as reported)
Solicitation date
Jan 1, 2019

Contract details

Subcontracting plan
Individual subcontract planF
Major program
Id/iq parent award for phase i clinical trials for development of neurotherapeutics
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jun 28, 2019Base obligation at award: $387,029
Latest action
Sep 17, 2025 — Funding onlyModification P00005; obligation change -$271,629; funding only: changes obligations, not scope
Latest substantive action
Aug 4, 2021 — Supplemental agreement (within scope)Modification P00003
Latest funding action
Sep 17, 2025 — Funding onlyModification P00005; obligation change -$271,629; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Funding only3
  • Supplemental agreement (within scope)1
  • Option exercised1
6 actions recorded, Jun 28, 2019 to Sep 17, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$271,629
Latest action: change in base and all options
-$271,629

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Multiple awardM
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N950
Transactions recorded under this award key
6

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N95A
Treasury accounts
  • 075-2019/2019-0886-000
  • 075-2020/2020-0886-000
Object classes
  • 25.2: Other services from non-Federal sources
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression